Register by Aug. 28 to Attend SITC’s September Workshops
Discounted rate for students now available for SITC’s workshops on cancer immune responsiveness and adoptive cellular therapies!
SITC 2019 General Registration Now Open!New session, presentation and speaker information now available!
SITC Career ConnectionsConnecting talent seekers with job seekers at all career levels throughout the cancer immunotherapy field
SITC Webinar: I-O Highlights from ASCO 2019
Join leading experts for a free webinar on Aug. 28 at Noon EDT to learn the latest advances in cancer immunotherapy emerging from the 2019 American Society of Clinical Oncology Annual Meeting.
JITC Increases Impact Factor to 8.676The Journal for ImmunoTherapy of Cancer (JITC), SITC’s open access, peer-reviewed online journal, has increased its impact factor to 8.676.
New Online Patient Course Available: Understanding Cancer Immunotherapy Access SITC’s dedicated resource for patients and caregivers to learn about cancer immunotherapy
Now Available: SITC Cancer Immunotherapy Guidelines – Squamous cell carcinoma of the head and neck (HNSCC)Learn up-to-date consensus recommendations for immunotherapy of head and neck cancers in this recently published SITC Cancer Immunotherapy Guidelines manuscript.
NOW AVAILABLE: SITC's Guide to Managing Immunotherapy Toxicity A new handbook from SITC for clinicians providing thorough coverage of the toxicity and management of adverse events for immune checkpoint inhibitors.
Join Patrick Hwu, MD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.
Inspire the Next Generation of Cancer Immunotherapy Leaders
Advance the science of cancer immunotherapy and help young investigators tackle hurdles facing the field with a gift to the SITC Forward Fund.
Explore resources and educational opportunities for cancer patients and those who advocate for them.
Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.
Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.
I was there and came back with so many great take home messages! 1. Always have an elevator speech ready. I have definitely screwed up some elevator encounters because I didn't have anything to say. I once even rode an uber with an important guy at ASCO ...
Hi Ann Great tips! I hope to be able to attend future meetings! Sent from my iPhone, please excuse any typos and brevity. The information contained in this electronic e-mail transmission and any attachments are intended only for the use of the individual ...
We just finished up a 1.5 day meeting in Seattle with 88 diverse and inspiring women who shared and learned from each other. Thank you to SITC, the sponsors, Lisa Butterfield, and the entire planning committee for giving us this opportunity. I have ...
Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com